Skip to main content
Tech.euFundingExplorerBeta

Abalos Therapeutics

Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.

Abalos Therapeutics has raised €43M across 1 funding round from 8 investors, most recently a Series A round in Oct 2021. Based in Essen, Germany; active in Healthtech. Data as of 28 Oct 2026.

Essen, Germanyabalos-tx.com ↗
Healthtech
← All companies
Total raised
€43M
€43,000,000
Funding rounds
1
Investors
8
distinct backers
Active since
2021-10
latest 2021-10

Funding by year

EUR raised per year
Abalos Therapeutics — funding by year — interactive chart.
Data table
Abalos Therapeutics — funding by year
2021€43M

Signals

High confidence
Raise-next likelihood8
base rate 44% for Series A
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2021-10-12Series A€43MBoehringer Ingelheim Venture Fund,Coparion,Gründerfonds Ruhr,High-Tech Gründerfonds (HTGF),Hx Bio Ventures,NRW.BANK+2 moreView deal →

Investors

8
Boehringer Ingelheim Venture FundCoparionGründerfonds RuhrHigh-Tech Gründerfonds (HTGF)Hx Bio VenturesNRW.BANKSeventure PartnersVentura BioMed

Related news

Similar companies

same sector or country

Global coverage: FundingData